Terms: = Lung cancer AND TPR, P12270, 7175 AND Prognosis
5 results:
1. Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
Chang W; Li H; Cheng Y; He H; Ou W; Wang SY
Front Immunol; 2023; 14():1171145. PubMed ID: 37081889
[TBL] [Abstract] [Full Text] [Related]
2. Nucleoporin tpr promotes tRNA nuclear export and protein synthesis in lung cancer cells.
Chen M; Long Q; Borrie MS; Sun H; Zhang C; Yang H; Shi D; Gartenberg MR; Deng W
PLoS Genet; 2021 Nov; 17(11):e1009899. PubMed ID: 34793452
[TBL] [Abstract] [Full Text] [Related]
3. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination.
Liu B; Liu L; Hu M; Qian K; Li Y
Thorac Cancer; 2016 Sep; 7(5):549-555. PubMed ID: 27766779
[TBL] [Abstract] [Full Text] [Related]
4. Expression and clinical role of small glutamine-rich tetratricopeptide repeat (tpr)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.
Xue Q; Lv L; Wan C; Chen B; Li M; Ni T; Liu Y; Liu Y; Cong X; Zhou Y; Ni R; Mao G
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1539-49. PubMed ID: 23857189
[TBL] [Abstract] [Full Text] [Related]
5. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract] [Full Text] [Related]
